Galderma Group AG (SWX:GALD)
Switzerland · Delayed Price · Currency is CHF 127.50
-2.50 (-1.92%)
Jul 31, 2025, 5:31 PM CET
Theseus Pharmaceuticals Market Cap
Galderma Group AG has a market cap or net worth of 30.27 billion as of July 31, 2025. Its market cap has increased by 73.38% in one year.
Market Cap
30.27B
Enterprise Value
32.17B
Revenue
3.73B
Ranking
n/a
PE Ratio
100.86
Stock Price
$127.50
Market Cap Chart
Since March 22, 2024, Galderma Group AG's market cap has increased from 15.20B to 30.27B, an increase of 99.08%. That is a compound annual growth rate of 66.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 30, 2025 | 30.86B | 29.09% |
| Dec 30, 2024 | 23.91B | 57.25% |
| Mar 22, 2024 | 15.20B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 223.18B |
| Novartis AG | 183.36B |
| Lonza Group AG | 40.98B |
| Alcon | 36.49B |
| Sandoz Group AG | 20.49B |
| Straumann Holding AG | 17.33B |
| Sonova Holding AG | 13.86B |
| Ypsomed Holding AG | 5.58B |